Sloveenia -
sloveeni -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
advantage 40
elanco animal health gmbh alfred -
Euroopa Liit -
sloveeni -
EMA (European Medicines Agency)
dovato
viiv healthcare b.v. - dolutegravir natrij, lamivudine - okužbe z virusom hiv - antivirusi za sistemsko uporabo - dovato je primerna za zdravljenje virusom humane imunske pomanjkljivosti tipa 1 (hiv-1) okužbe v odrasli in mladostniki nad 12 let starosti, ki tehta najmanj 40 kg, z ni znano, ali obstaja sum, odpornost na integrase zaviralec razred, ali lamivudine.
Euroopa Liit -
sloveeni -
EMA (European Medicines Agency)
staquis
pfizer europe ma eeig - crisaborole - dermatitis, atopic - drugi dermatološki preparati - staquis je indiciran za zdravljenje blage do zmerno atopijskega dermatitisa pri odraslih in pediatričnih bolnikih od 2. leta starosti s ≤ 40% telesne površine (bsa), ki.
Euroopa Liit -
sloveeni -
EMA (European Medicines Agency)
veklury
gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.
Euroopa Liit -
sloveeni -
EMA (European Medicines Agency)
ronapreve
roche registration gmbh - casirivimab, imdevimab - covid-19 virus infection - imunski sera in imunoglobulini, - ronapreve is indicated for:treatment of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19 (see section 4. prevention of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg (see section 4. the use of ronapreve should take into account information on the activity of ronapreve against viral variants of concern. glej poglavja 4. 4 in 5.
Euroopa Liit -
sloveeni -
EMA (European Medicines Agency)
xevudy
glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - imunski sera in imunoglobulini, - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.